Protein Discovery Could Unlock Youthful Brains

Researchers identify key protein that drives brain aging, opening door to potential therapies

Apr. 12, 2026 at 2:41pm by

An abstract, highly structured painting in soft, earthy tones depicting intricate biological patterns and molecular structures, conceptually representing the complex forces involved in the FTL1 protein's impact on brain aging.A scientific visualization of the FTL1 protein's central role in reshaping brain cells and driving age-related memory decline.San Francisco Today

Scientists at UC San Francisco have identified a protein called FTL1 that appears to be a major driver of brain aging, particularly in the hippocampus - the brain's learning and memory hub. Increasing FTL1 levels in young mice led to simplified neuron structures, while reducing FTL1 in older mice resulted in improved memory and neural connectivity, suggesting the potential to reverse age-related cognitive decline.

Why it matters

This research represents a breakthrough in understanding the biology of aging, shifting the paradigm from viewing it as an inevitable process to a condition that can potentially be treated. By identifying a specific protein that catalyzes brain aging, scientists may be able to develop therapies that restore cognitive function in older adults, rather than just managing decline.

The details

The researchers found that older mice had higher levels of the FTL1 protein, which correlated with fewer neural connections and poorer performance on cognitive tests. When scientists boosted FTL1 levels in young mice, their neurons lost the complex branching structures essential for healthy brain function. Conversely, reducing FTL1 in older mice led to measurable improvements in memory and neural connectivity, suggesting the potential to reverse age-related impairments. FTL1's role in cellular metabolism was also identified as a key factor, as higher levels of the protein slow down energy production in brain cells, exacerbating aging. However, treating cells with a metabolism-boosting compound mitigated these negative effects.

  • The study was published in April 2026.

The players

UC San Francisco

A public research university and medical center located in San Francisco, California, known for its pioneering work in the biological sciences.

Saul Villeda

The lead author of the study and a researcher at UC San Francisco focused on the biology of aging.

Got photos? Submit your photos here. ›

What they’re saying

“It's a 'hopeful time to be working on the biology of aging.'”

— Saul Villeda, Lead Researcher

What’s next

Researchers believe their findings could pave the way for therapies that target FTL1 or its metabolic effects, potentially leading to treatments that restore cognitive function in older adults.

The takeaway

This research represents a significant shift in how we understand and approach aging, moving from viewing it as an inevitable process to a condition that can potentially be treated. By identifying a key protein driver of brain aging, scientists may be able to develop therapies that reverse, rather than just manage, age-related cognitive decline.